Market Overview

Benzinga's Top #PreMarket Losers

Benzinga's M&A Chatter for Monday March 30, 2015
Benzinga's Volume Movers
Expensive Drugs Spur UnitedHealth, Other PBM Mergers (Investor's Business Daily)
This Upcoming Event Could Affect Sarepta Therapeutics Investors
Bank Of America Upgrades Sarepta Therapeutics On 'Increased Conviction' Of Drug Approval

Catamaran (NASDAQ: CTRX) shares fell 9.27% to $47.00 in the pre-market trading after the company reported Q4 results.

Sarepta Therapeutics (NASDAQ: SRPT) dipped 4.89% to $28.01 after the company reported weaker-than-expected results.

Magic Software Enterprises (NASDAQ: MGIC) shares dropped 2.19% to $9.39 in pre-market trading after rising 6.31% on Wednesday.

InterMune (NASDAQ: ITMN) dipped 2.08% to $31.51 in the pre-market session after dropping 14.87% on Wednesday.

Posted-In: PreMarket LosersNews Movers & Shakers Pre-Market Outlook Markets


Related Articles (ITMN + CTRX)

Around the Web, We're Loving...